Stem cell therpay market global revenue, trends, growth, share, size and forecast to 2022

Page 1

Stem Cell Therapy Market By Treatments (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Applications (Oncology, Eye Diseases, Central Nervous System Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Immune System Disorders), End-users (Hospitals, Ambulatory Surgical Centers) and Geography – Global Opportunity Analysis and Industry Forecast, 2014-2022

SCALAR MARKET RESEARCH INC. OCTOBER 2016

1


Table of Contents

1

Introduction .................................................................................................................................. 11

2

Market Overview .......................................................................................................................... 12 2.1

Definitions ............................................................................................................................. 12

2.2

Research Methodology ......................................................................................................... 13

2.3

Market Segmentation ........................................................................................................... 15

2.4

Assumptions .......................................................................................................................... 16

3

Executive Summary ....................................................................................................................... 17

4

Market Dynamics .......................................................................................................................... 23

6

7

4.2

Restraints .............................................................................................................................. 26

4.3

Opportunities ........................................................................................................................ 27

4.4

Trends ................................................................................................................................... 27

PL

E

Drivers ................................................................................................................................... 24

Industry Analysis ........................................................................................................................... 28 Industry Overview ................................................................................................................. 28

5.2

Regulatory Analysis ............................................................................................................... 30

M

5.1

5.2.1

Europe ........................................................................................................................... 30

5.2.2

U.S. FDA......................................................................................................................... 30

SA

5

4.1

5.3

Pipeline Analysis.................................................................................................................... 31

5.4

Pricing Analysis...................................................................................................................... 34

Stem Cell Therapy Market, by Treatments ................................................................................... 35 6.1

Market Overview .................................................................................................................. 35

6.2

Market Share Segmentation ................................................................................................. 36

6.3

Revenue Segmentation ......................................................................................................... 38

6.4

Treatments ............................................................................................................................ 39

6.4.1

Allogeneic Stem Cell Therapy........................................................................................ 39

6.4.2

Autologous Stem Cell Therapy ...................................................................................... 41

Stem Cell Therapy Market, by Applications .................................................................................. 43 7.1

Market Overview .................................................................................................................. 43

7.2

Market Share Segmentation ................................................................................................. 45

2


7.4

Applications........................................................................................................................... 48

7.4.1

Oncology ....................................................................................................................... 48

7.4.2

Eye Diseases .................................................................................................................. 50

7.4.3

Central Nervous System Diseases ................................................................................. 51

7.4.4

Musculoskeletal Diseases ............................................................................................. 52

7.4.5

Wound & Injuries .......................................................................................................... 53

7.4.6

Metabolic Disorders ...................................................................................................... 54

7.4.7

Cardiovascular Disorders .............................................................................................. 55

7.4.8

Immune System Disorders ............................................................................................ 56

Stem Cell Therapy Market, by End-Users ..................................................................................... 58 Market Overview .................................................................................................................. 58

8.2

Market Share Segmentation ................................................................................................. 59

8.3

Revenue Share Segmentation ............................................................................................... 61

8.4

End-Users .............................................................................................................................. 62

PL

E

8.1

8.4.1

Hospitals........................................................................................................................ 62

8.4.2

Ambulatory Surgical Centers ........................................................................................ 63

M

9

Revenue Segmentation ......................................................................................................... 47

Stem Cell Therapy Market, By Regions ......................................................................................... 64 9.1

Market Share Segmentation ................................................................................................. 65

9.2

Revenue Segmentation ......................................................................................................... 67

9.3

North America ....................................................................................................................... 68

9.3.1

SA

8

7.3

By Regions ..................................................................................................................... 69

9.3.1.1

U.S. ............................................................................................................................ 69

9.3.1.2

Canada ...................................................................................................................... 69

9.3.2

By Treatments ............................................................................................................... 70

9.3.3

By Applications .............................................................................................................. 71

9.3.4

By End-Users ................................................................................................................. 72

9.4

Europe ................................................................................................................................... 73

9.4.1

By Regions ..................................................................................................................... 74

9.4.1.1

Germany.................................................................................................................... 74

9.4.1.2

U.K ............................................................................................................................. 74

3


9.4.1.3

France........................................................................................................................ 74

9.4.1.4

Spain .......................................................................................................................... 74

9.4.1.5

Rest of Europe ........................................................................................................... 75

9.4.2

By Treatments ............................................................................................................... 76

9.4.3

By Applications .............................................................................................................. 77

9.4.4

By End-Users ................................................................................................................. 78

Asia-Pacific ............................................................................................................................ 79

9.5.1

By Regions ..................................................................................................................... 80

9.5.1.1

China ......................................................................................................................... 80

9.5.1.2

India........................................................................................................................... 80

9.5.1.3

Japan ......................................................................................................................... 80

9.5.1.4

South Korea ............................................................................................................... 80

E

9.5

By Treatments ............................................................................................................... 82

9.5.3

By Applications .............................................................................................................. 83

9.5.4

By End-Users ................................................................................................................. 84

Rest of the World (ROW) ...................................................................................................... 85 By Regions ..................................................................................................................... 86

M

9.6.1 9.6.1.1

Latin America ............................................................................................................ 86

9.6.1.2

Middle East & Africa.................................................................................................. 86

SA

9.6

PL

9.5.2

9.6.2

By Treatments ............................................................................................................... 87

9.6.3

By Applications .............................................................................................................. 88

9.6.4

By End-Users ................................................................................................................. 89

10 Competitive Landscape ................................................................................................................. 90 10.1

Key Innovator Companies ..................................................................................................... 90

11 Key Market Players ....................................................................................................................... 92 11.1

Vericel Corporation ............................................................................................................... 92

11.1.1

Overview ....................................................................................................................... 92

11.1.2

Key Strategies................................................................................................................ 92

11.1.3

Recent Developments ................................................................................................... 92

11.2

Stem Cells, Inc. ...................................................................................................................... 93

11.2.1

Overview ....................................................................................................................... 93

4


11.2.2

Key Strategies................................................................................................................ 93

11.2.3

Recent Developments ................................................................................................... 93

11.3

Mesoblast Ltd........................................................................................................................ 94

11.3.1

Overview ....................................................................................................................... 94

11.3.2

Key Strategies................................................................................................................ 94

11.3.3

Recent Developments ................................................................................................... 94

11.4

Gamida Cell ........................................................................................................................... 95

11.4.1

Overview ....................................................................................................................... 95

11.4.2

Key Strategies................................................................................................................ 95

11.4.3

Recent Developments ................................................................................................... 95

11.5

Osiris Therapeutics, Inc. ........................................................................................................ 96 Overview ....................................................................................................................... 96

11.5.2

Key Strategies................................................................................................................ 96

11.5.3

Recent Developments ................................................................................................... 96

PL

11.6

E

11.5.1

Chiesi Farmaceutici S.p.A. ..................................................................................................... 97 Overview ....................................................................................................................... 97

11.6.2

Key Strategies................................................................................................................ 97

11.6.3

Recent Developments ................................................................................................... 97

ReNeuron Group, plc ............................................................................................................ 98

SA

11.7

M

11.6.1

11.7.1

Overview ....................................................................................................................... 98

11.7.2

Key Strategies................................................................................................................ 98

11.7.3

Recent Developments ................................................................................................... 98

12 Scalar 360 Degree Market Perspective ......................................................................................... 99 13 Appendix ..................................................................................................................................... 100

5


List of Tables

Research Methodology ..................................................................................................... 13

Table 2.

Assumptions ...................................................................................................................... 16

Table 3.

Global Stem Cell Therapy Market Size (US$ billion), (2016-2022).................................... 18

Table 4.

Global Stem Cell Therapy Market Summary ..................................................................... 22

Table 5.

Stem Cell Therapy Market in emerging countries ............................................................ 27

Table 6.

Stem Cell Therapeutic Products Available in the Market ................................................. 28

Table 7.

Stem Cell Therapies in Phase 3 & Pre-registration Stage of the Development (2015) ..... 33

Table 8.

Companies with Number of Stem Cell Therapies in Pipeline (2015) ................................ 34

Table 9.

Average Treatment Costs.................................................................................................. 34

Table 10.

Global Stem Cell Therapy Market Size (US$ billion), By Treatments (2014-2022) ........... 38

Table 11.

Global Allogeneic Stem Cell Therapy Market Size (US$ billion), By Regions (2014-2022) 39

Table 12.

Global Autologous Stem Cell Therapy Market Size (US$ billion),By Regions (2014-2022) 41

Table 13.

Global Stem Cell Therapy Market Size (US$ billion), By Applications (2014-2022) .......... 47

Table 14.

Focused Areas in Oncology for Stem Cell Therapies......................................................... 48

Table 15.

Global Stem Cell Therapy Market for Oncology; Market Size (US$ billion) (2014-2022) . 49

Table 16.

Global Stem Cell Therapy Market for Eye Diseases; Market Size (US$ billion) (2014-2022) 50

SA

M

PL

E

Table 1.

Table 17. Global Stem Cell Therapy Market for Central Nervous System Diseases; Market Size (US$ billion) (2014-2022)............................................................................................................................... 51 Table 18. Global Stem Cell Therapy Market for Musculoskeletal Diseases; Market Size (US$ billion) (2014-2022)52 Table 19. 2022)

Global Stem Cell Therapy Market for Wound & Injuries; Market Size (US$ billion) (201453

Table 20. Global Stem Cell Therapy Market for Metabolic Disorders; Market Size (US$ billion) (2014-2022)54 Table 21. Global Stem Cell Therapy Market for Cardiovascular Disorders; Market Size (US$ billion) (2014-2022)55 Table 22.

Focused Areas in Immune System Disorders for Stem Cell Therapies ............................. 56

Table 23. Global Stem Cell Therapy Market for Immune System Disorders; Market Size (US$ billion) (2014-2022)............................................................................................................................... 57 Table 24.

Global Stem Cell Therapy Market Size (US$ billion), By End-users (2014-2022) .............. 61

6


Table 25.

Global Stem Cell Therapy Market for Hospitals; Market Size (US$ billion) (2014-2022) . 62

Table 26. Global Stem Cell Therapy Market for Ambulatory Surgical Centers; Market Size (US$ billion) (2014-2022)............................................................................................................................... 63 Table 27.

Global Stem Cell Therapy Market Size (US$ billion), By Regions (2014-2022) ................. 67

Table 28.

Stem Cell Therapy Market in North America; Market Size (US$ billion) (2014-2022) ...... 68

Table 29.

Stem Cell Therapy Market in U.S; Market Size (US$ billion), (2014-2022) ....................... 69

Table 30.

Stem Cell Therapy Market in Canada; Market Size (US$ billion), (2014-2022) ................ 69

Table 31. Stem Cell Therapy Market in North America; Market Size (US$ billion), By Treatment (2014-2022)..........................................................................................................................................70 Table 32. Stem Cell Therapy Market in North America; Market Size (US$ billion), By Applications (2014-2022)..........................................................................................................................................71 Table 33. Stem Cell Therapy Market in North America; Market Size (US$ billion), By End-users (2014-2022)........................................................................................................................................... 72 Stem Cell Therapy Market in Europe; Market Size (US$ billion)....................................... 73

Table 35.

Stem Cell Therapy Market in Germany; Market Size (US$ billion),(2014-2022) .............. 74

Table 36.

Stem Cell Therapy Market in U.K; Market Size (US$ billion), (2014-2022) ....................... 74

Table 37.

Stem Cell Therapy Market in France; Market Size (US$ billion),(2014-2022) .................. 74

Table 38.

Stem Cell Therapy Market in Spain; Market Size (US$ billion), (2014-2022).................... 74

Table 39.

Stem Cell Therapy Market in Rest of Europe; Market Size (US$ billion), (2014-2022)..... 75

M

PL

E

Table 34.

SA

Table 40. Stem Cell Therapy Market in Europe; Market Size (US$ billion), By Treatment (20142022).................. ................................................................................................................................... 76 Table 41. Stem Cell Therapy Market in Europe; Market Size (US$ billion), By Applications (20142022)........... .......................................................................................................................................... 77 Table 42. Stem Cell Therapy Market in Europe; Market Size (US$ billion), By End-users (20142022)............ ......................................................................................................................................... 78 Table 43.

Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion) ................................ 79

Table 44.

Stem Cell Therapy Market in China; Market Size (US$ billion), (2014-2022) ................... 80

Table 45.

Stem Cell Therapy Market in India; Market Size (US$ billion), (2014-2022) .................... 80

Table 46.

Stem Cell Therapy Market in Japan; Market Size (US$ billion), (2014-2022) ................... 80

Table 47.

Stem Cell Therapy Market in South Korea; Market Size (US$ billion), (2014-2022)......... 80

Table 48.

Stem Cell Therapy Market in Rest of Asia-Pacific; Market Size (US$ billion), (2014-2022) 81

Table 49. 2022)

Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By Treatment (201482

7


Table 50. Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By Applications (2014-2022)83 Table 51. 2022)

Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By End-users (201484

Table 52.

Stem Cell Therapy Market in Rest of the World (ROW); Market Size (US$ billion) .......... 85

Table 53.

Stem Cell Therapy Market in Latin America; Market Size (US$ billion), (2014-2022) ...... 86

Table 54.

Stem Cell Therapy Market in Middle East & Africa; Market Size (US$ billion), (2014-2022) 86

Table 55. Stem Cell Therapy Market in Rest of the World (ROW); Market Size (US$ billion), By Treatment (2014-2022)......................................................................................................................... 87 Table 56. Stem Cell Therapy Market in Rest of the World (ROW); Market Size (US$ billion), By Applications (2014-2022) ...................................................................................................................... 88 Table 57. Stem Cell Therapy Market in Rest of the World; Market Size (US$ billion), By End-users (2014-2022)..........................................................................................................................................89 Key Innovator Companies ................................................................................................. 90

Table 59.

Acronyms ........................................................................................................................ 100

SA

M

PL

E

Table 58.

8


List of Figures

Research Methodology ..................................................................................................... 14

Figure 2.

Global Stem Cell Therapy Market Share(%), By Regions (2016 & 2022) .......................... 19

Figure 3.

Global Stem Cell Therapy Market Share(%), By Treatments (2016 & 2022) .................... 19

Figure 4.

Global Stem Cell Therapy Market Share(%), By Applications (2017 & 2022) ................... 20

Figure 5.

Global Stem Cell Therapy Market Share(%), By End-users (2016 & 2022) ....................... 21

Figure 6.

Stem Cell Therapy by Stage of Development (2015) ........................................................ 31

Figure 1.

Stem Cell Therapy by Therapeutic Area (2015) ................................................................ 32

Figure 2.

Global Stem Cell Therapy Market Size (US$ billion), By Treatments (2015) .................... 35

Figure 3.

Global Stem Cells Therapy Market Share (%), By Treatments (2016 & 2022) ................. 36

Figure 4.

Global Stem Cells Therapy Market Size (US$ billion), By Treatments (2014-2022) ......... 38

Figure 5.

Global Allogeneic Stem Cell Therapy Market Size (US$ billion), By Regions (2016 & 2022) 39

Figure 6.

Global Autologous Stem Cell Therapy Market Size (US$ billion), By Regions (2015 & 2022 41

Figure 7.

Market Attractiveness for Major Stem Cell Therapy Applications (2017) ........................ 44

Figure 8.

Forecasted Global Stem Cell Therapy Market Share (%), By Applications (2017 & 2022) 45

Figure 9.

Global Stem Cell Therapy Market Size (US$ billion), By Applications (2017 & 2022) ....... 47

SA

M

PL

E

Figure 1.

Figure 10. 2022)

Global Stem Cells Therapy Market for Oncology; Market Size (US$ billion) (2017 & 49

Figure 11. 2022)

Global Stem Cells Therapy Market for Eye Diseases; Market Size (US$ billion) (2017 & 50

Figure 12. Global Stem Cells Therapy Market for Central Nervous System Diseases; Market Size (US$ billion) (2017 & 2022) ................................................................................................................... 51 Figure 13. Global Stem Cells Therapy Market for Musculoskeletal Diseases; Market Size (US$ billion) (2017 & 2022) ........................................................................................................................... 52 Figure 14. Global Stem Cells Therapy Market for Wound & Injuries; Market Size (US$ billion) (2017 & 2022) 53 Figure 15. Global Stem Cells Therapy Market for Eye Metabolic Disorders; Market Size (US$ billion) (2017 & 2022) ........................................................................................................................... 54 Figure 16. Global Stem Cells Therapy Market for Cardiovascular Disorders; Market Size (US$ billion) (2017 & 2022) ........................................................................................................................... 55

9


Figure 17. Global Stem Cells Therapy Market for Immune System Disorders; Market Size (US$ billion) (2017 & 2022) ........................................................................................................................... 56 Figure 18.

Global Stem Cell Therapy Market Size (US$ billion), By End-users (2015) ................... 58

Figure 19.

Global Stem Cell Therapy Market Share(%), By End-Users (2016 & 2022) .................. 59

Figure 20.

Global Stem Cells Therapy Market Size (US$ billion), By End-users (2014-2022) ....... 61

Figure 21. 2022)

Global Stem Cells Therapy Market for Hospitals; Market Size (US$ billion) (2016 & 62

Figure 22. Global Stem Cells Therapy Market for Ambulatory Surgical Centers; Market Size (US$ billion) (2016 & 2022) ........................................................................................................................... 63 Global Stem Cell Therapy Market Share (%), By Major Regions(2015 & 2022) ............ 65

Figure 24.

Top 5 Countries, By Market Share (%) (2016) ............................................................... 66

Figure 25.

Stem Cell Therapy Market in North America; Market Size (US$ billion)(2014-2022)... 68

Figure 26. (2014-2022)

Stem Cell Therapy Market in North America; Market Size (US$ billion), By Treatment 70

E

Figure 23.

PL

Figure 27. Stem Cell Therapy Market in North America; Market Size (US$ billion), By End-users (2014- 2022) 72 Stem Cell Therapy Market in Europe; Market Size (US$ billion)(2014-2022) ............... 73

Figure 29. 2022)

Stem Cell Therapy Market in Europe; Market Size (US$ billion), By Treatment (201476

Figure 30. 2022)

Stem Cell Therapy Market in Europe; Market Size (US$ billion), By End-users (201478

Figure 31.

Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion)(2014-2022) ........ 79

Figure 32. (2014-2022)

Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By Treatment 82

Figure 33. (2014-2022)

Stem Cell Therapy Market in Asia-Pacific; Market Size (US$ billion), By End-users 84

Figure 34.

Stem Cell Therapy Market in Rest of the World; Market Size (US$ billion) (2014-2022) 85

SA

M

Figure 28.

Figure 35. Stem Cell Therapy Market in Rest of the World; Market Size (US$ billion), By Treatment (2014-2022)......................................................................................................................... 87 Figure 36. Stem Cell Therapy Market in Rest of the World (ROW); Market Size (US$ billion), By End-users (2014-2022) .......................................................................................................................... 89

10


2 Market Overview 2.1 Definitions Global stem cell therapy market is defined as the market size and market share estimation of the various segments of the stem cell therapy market, capturing ongoing drivers, trends, challenges of the market, industry analysis involving the regulatory analysis, and studying about the major participants and players in stem cell therapy market environment. The 'Global Stem Cell Therapy Market – Market Size and Forecast (2014–2022)' report includes market size and forecast estimates for the period 2014 to 2022. The scope of this report is commercially available regenerative stem cell therapy

E

products, pipeline analysis, and application of stem cell therapies in different

PL

diseases. The report segments the market by treatments, applications, end-users, and regions. The report has 2014 as the historic year, 2015 as base year and years 2016 to 2022 as forecast years.

M

This report defines stem cell therapy as–

SA

Stem cell therapy is defined as the introduction of the stem cells into the damaged or diseased tissue. These stem cells posses the ability to renew themselves and give rise to other cells, which in turn replaces the damaged organs and tissues in the body. Stem cell therapy comes under the umbrella of the global regenerative medicines.

Allogeneic Stem cell therapy treatment type as– Allogeneic transplant is stem cell transplant treatment in which the stem cell are received by the donor which can be a relative, a family member, or a third person. Autologous Stem cell therapy treatment type as– Allogeneic transplant is stem cell transplant treatment in which the stem cell are received by the patient from his own blood.

12


2.2 Research Methodology The market study of stem cell therapy market incorporates prolonged two-way approaches, secondary and primary research to collect the information commercially and study the market. The data collection part was focused, and related to capturing the whole market from various perspective. Data collected from multiple sources was logically linked and analyzed by our analysts. Secondary Data Secondary data gathering procedure, with subsequent references such as company websites, journals, magazines, directories, databases such as Bloomberg, Hoovers, Factiva, company annual reports, press releases, white papers, and government publishing sources also have been taken into consideration. Data from these

E

sources has been used to obtain industry analysis, company profiles, and other key

market perspective. Research Methodology

Report Parameter

Industry Analysis

SA

Market Size, Share, Revenue

M

Table 1.

PL

areas such as market drivers, opportunities, and trends from stem cell therapy

Secondary Source Company Annual Reports, SEC Filings, Financials, Press Releases, Directories, Journals. Company websites, Market journals, White papers, Magazines, other Market studies.

Competitive Landscape

Company Annual Reports, Financials, Press Releases, Investors Relations, Directories, Journals.

Primary Data Primary data is the most important data in the research study. Primary data has been considered and linked to the report to make the study more crisp and informative. Structured interviews with industry specialists, VPs, CEO’s, directors, technology consultants were taken to collect the key primary data. The primary data was focused on both, the demand and supply side of the market. Market Engineering

13


was carried out from the data, and excessive analysis has been done on it. Primary data was also considered extensively in validating the secondary content. Market engineering process involved both top-down and bottom-up approach to estimate the market size and market forecast and segment the market into more sub-segments. Market size estimation Both, top-down and bottom-up approaches were used to estimate the size of the global stem cell therapy market. Research Methodology Top-down

Global

Global Market Size

Segment-specific Market Size

PL

Market-specific Revenues of Key Market Players

E

Market Size

Regional

M

Revenues of Key Market Players

Bottom-up

SA

Figure 1.

14

Market Size


2.3 Market Segmentation

Stem Cell Therapy Market

• North America

• Ambulatory Surgical Centers

• Europe

E 15

Regions

• Hospitals

PL

• Autologous Stem Cell Therapy

• Oncology •Central Nervous System Diseases •Eye Diseases •Musculoskeletal Diseases •Wound & Injuries •Metabolic Disorders •Cardiovascular Disorders •Immune System Disorders

End-users

M

•Allogeneic Stem Cell Therapy

Applications

SA

Treatments

• Asia-Pacific • Rest of the World


3 Executive Summary Stem cell therapy is defined as the introduction of the stem cells into the damaged or diseased tissue. These stem cells posses the ability to renew themselves and give rise to other cells, which in turn replaces the damaged organs and tissues in the body. Stem cell therapy comes under the umbrella of the global regenerative medicines. The stem cell therapy market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of stem cell population and their preservation will be essential for

E

commercialization of stem cell therapies. Thus, large numbers of key companies such as Baxter International., Teva Pharmaceutical, and others are in constant

PL

efforts to develop stem cell therapies. For which, these companies are rigorously increasing their research and development expenses on clinical trials to introduce stem cell therapies which would ultimately drive the market growth. Furthermore,

M

demand for stem cell therapies is also expected to increase due to the rise in the incidence of life-threatening diseases such as cancer, cardiovascular disorders, and

SA

others. For these diseases, stem cell therapies have proven a promising option for the disease diagnosis and mitigation. However, a strict regulatory framework for the stem cell therapies to develop these products restricts companies to invest in this market, leading to hampering the market growth during the future period. The major revenue opportunities are expected to come from application sectors such as Oncology, Cardiovascular disorders, and immune system disorders. Whereas cardiovascular disorders will account for 50.4% of the total revenue generated by 2022, oncology and immune system disorders will demand a great potential towards stem cell therapy market. Allogeneic based stem cell therapy will dominate in the stem cell therapy market while autologous based stem cell therapy will see the decrease during the forecast as large number of stem cell therapies for cardiovascular diseases are already in phase 3 and pre-registration stages. Areas for investment in the stem cell therapy market will focus on improving research and

17


Figure 2. Global Stem Cell Therapy Market Share(%), By Regions (2016 & 2022)

3.6% 13.2% 3.5% 12.0%

North America 57.1%

Europe Asia-Pacif ic

25.5% 59.1%

Rest of the World

E

26.1%

PL

Source: Scalar Market Research Analysis

SA

M

Figure 3. Global Stem Cell Therapy Market Share(%), By Treatments (2016 & 2022)

51.7%

37.7% 48.3%

Autologous Allogeneic

62.3%

Source: Scalar Market Research Analysis

Inside circle shows the market share for the year 2016 & outside circle shows market share for the year 2022.

19


Table 4.

Global Stem Cell Therapy Market Summary

Market Size (US$ billion) 2016

2022

CAGR% (2016-2022)

11.99

60.94

31.1

Global Stem Cell Therapy Market

Treatment

Total Autologous Stem Cell Therapy Allogeneic Stem Cell Therapy Oncology Eye Diseases

Musculoskeletal Diseases

E

Wound & Injuries Metabolic Disorders

PL

Applications

Central Nervous System Diseases

Cardiovascular Disorders

Ambulatory Surgical Centers

M

Hospitals

SA

End-users

Immune System Disorders

Regions

North America Europe Asia-Pacific

Rest of the World Source: Scalar Market Research Analysis

Note: '*’ represents CAGR (2017-2022) as stem cell therapies for these diseases are still in experimental stages and are expected to enter the market in 2017-2018.

22


SA

M

PL

E

4 Market Dynamics

23


4.1 Drivers Drivers

Impact on the Market 2014-2016

2017-2019

2020-2022

Increase in aging population and chronic diseases, and their need of alternative medicines

E

◑=Medium

PL

●=High

◔=Low

1. Increase in aging population and chronic diseases, and their need of

SA

M

alternative medicines

24


5 Industry Analysis 5.1 Industry Overview

The stem cell industry is still considered as an under-regulated industry. Large numbers of companies are marketing unproven treatments which can be very harmful to the patients. There are mostly 15 stem cell therapeutic products available on the market and has been regulated. All other stem cell procedures are still in experimental stages. Hemacord; manufactured by New York Blood Center (NYBC); the cord blood product was approved by FDA in 2011, is excluded from the list along with four more cord

E

blood products approved since 2011. The following table gives the list of stem cell therapeutic products that are

PL

commercially available in the market and regulated. All the following products are authorized for sales and available in the market and are approved by or regulated by

No. 1

Stem Cell Therapeutic Products Available in the Market Product

SA

Table 6.

M

the federal agency.

Company

Country

Year of Release

2 3 4 5 6 7 8 9 10

28

Indication

Regulation


11 12 13 14 15

SA

M

PL

E

Source: Scalar Market Research Analysis

29


6 Stem Cell Therapy Market, by Treatments 6.1 Market Overview Figure 2.

Global Stem Cell Therapy Market Size (US$ billion), By Treatments

(2015)

USD 9.60 Billion

Allogeneic Stem Cell Therapy| US XX Billion

PL

E

Autologous Stem Cell Therapy |US XX Billion

On the basis of treatments, the global stem cell therapy market is segmented into

M

allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell treatment is expected to be the largest treatment segment of this market in 2016.

SA

This segment was valued at US XX billion and is expected to be valued at US XX billion in 2016. It is expected to have a XX% share of the total stem cell therapy market in 2016. It is also expected to be the fastest-growing market segment. This segment will grow at a CAGR of XX% between 2016 and 2022, to reach USXX billion by 2022.

35


6.3 Revenue Segmentation Figure 4.

Global Stem Cells Therapy Market Size (US$ billion), By Treatments

2016

Table 10.

Allogeneic TOTAL

2015

2016

M

2014

2017

2018

2020

18.12

20.71

14.34

15.31

11.38

11.33

2019

2020

SA

Autologous

2019

2021

2022

Global Stem Cell Therapy Market Size (US$ billion), By Treatments

(2014-2022) Treatment

2018

PL

Source: Scalar Market Research Analysis

9.06

8.38

7.23

2017

E

2015

6.20

5.78

4.77

4.83

3.67

4.04

2014

22.96

Allogeneic

28.03

Autologous

37.98

(2014-2022)

2021

2022

CAGR% (2016-2022)

31.1%

Source: Scalar Market Research Analysis

Allogeneic stem cell therapy treatment accounts for the largest treatment of the stem cell therapy market in 2015. This market segment is expected to grow at a CAGR of XX% from USXX billion in 2015 to US XX billion in 2022.

38


7 Stem Cell Therapy Market, by Applications 7.1 Market Overview

The applications segment of the Stem Cell Therapy market included in this report are Oncology

diseases,

Eye

Diseases,

Central

Nervous

System

Diseases,

Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Diseases, and Immune system disorders. Musculoskeletal diseases, wound & injuries, and eye diseases were the largest application segments in 2015, but is expected to lose its market share to cardiovascular diseases and oncology diseases

E

during the forecast period. This report gives the market size of stem cell therapy for eye diseases,

PL

musculoskeletal diseases, and wound & injuries application segments for years 2014 to 2016, considering these applications as widely accepted as safe and effectively proven by the medical community. All other application segments are still in

M

experimental stages and yet to be proven; thus their market sizes are forecasted

SA

from 2017 to 2022 accordingly.

43


Figure 7. Market Attractiveness for Major Stem Cell Therapy Applications (2017) Applications

Market Size

Growth Rate

Overall Attractiveness

Wound & Injuries Musculoskeletal Diseases Eye Diseases

Cardiovascular Disorders System

E

Immune Disorders

PL

Metabolic disorders

Oncology

SA

Diseases

M

Central Nervous System

●=Significantly Attractive

44

◑=Attractive

◔=Less Attractive


7.3 Revenue Segmentation Figure 9.

Global Stem Cell Therapy Market Size (US$ billion), By Applications (2017 & 2022)

Metabololic Disorders

3.02 30.72

1.28 2.74 0.47 9.15

Wound & Injuries

6.19 4.52 2.57 0.31 2.64 2.11

Eye Diseases

3.17 0.25

Table 13.

Global Stem Cell Therapy Market Size (US$ billion), By Applications

(2014-2022) Applications

SA

Source: Scalar Market Research Analysis

M

Oncology

2017

6.92

Musculoskeletal Diseases

Central Nervous System Diseases

2022

E

Cardiovascular Disorders

0.47

PL

Immune System Disorders

2014

2015

2016

2017

2018

2019

2020

2021

2022

CAGR% (2017-2022)

Oncology Eye Diseases Central Nervous System Diseases Musculoskeletal Diseases Wound & Injuries Metabolic Disorders Cardiovascular Disorders Immune System Disorders Total

31.3%

Source: Scalar Market Research Analysis

47


8 Stem Cell Therapy Market, by End-Users 8.1 Market Overview Figure 18.

Global Stem Cell Therapy Market Size (US$ billion), By End-users (2015)

USD 9.60 Billion

Hospitals| US XX Billion

PL

E

Ambulatory Surgical Centers |US XX Billion

On the basis of end-users, the global stem cell therapy market is segmented into hospitals and ambulatory surgical centers. Hospitals are expected to be the largest

M

end-user segment of this market in 2016. This segment is expected to be valued at US XX billion in 2016. It is expected to have a XX% share of the total stem cell

SA

therapy market in 2016. It is also expected to be the fastest-growing market segment. This segment will grow at a CAGR of XX% between 2016 and 2022, to reach US$ XX billion by 2022. However, the prevalence of ambulatory surgical centers is more in regulated markets as compared to non-regulated markets.

58


8.3 Revenue Share Segmentation Figure 20.

Global Stem Cells Therapy Market Size (US$ billion), By End-users

2016

2017

2018

Ambulatory Surgical Centers

21.05

16.07

30.08 12.31

2021

2022

PL

2015

M

2014

2016

2017

SA

Hospitals

2020

Global Stem Cell Therapy Market Size (US$ billion), By End-users (2014-

2022) End-Users

22.75

2019

Source: Scalar Market Research Analysis

Table 24.

9.45

17.25 7.27

13.12 5.61

10.00 4.34

7.65

3.50

2015

E

2014

Ambulatory Surgical Centres

6.10

2.83

4.87

Hospitals

39.89

(2014-2022)

2018

2019

2020

2021

2022

CAGR% (20162022)

TOTAL

31.1%

Source: Scalar Market Research Analysis

61


9 Stem Cell Therapy Market, By Regions The regional segments of the Stem Cell Therapy market included in this report are North America (NA), Europe (EU), Asia-Pacific (APAC), and the Rest of the World (ROW). North America was the largest regional segment in 2015, while North America, and Asia Pacific is expected to be the fastest-growing regional segment in

SA

M

PL

E

the forecast period.

64


9.1 Market Share Segmentation Figure 23.

Global Stem Cell Therapy Market Share (%), By Major Regions (2015 &

2022)

3.6% 13.2% 3.5% 12.0%

North America Europe

57.1% 59.1%

Rest of the World

SA

M

PL

26.1%

E

Asia-Pacif ic

25.5%

Source: Scalar Market Research Analysis

Inside circle shows the market share for the year 2016 & outside circle shows market share for the year 2022.

65


10 Competitive Landscape 10.1 Key Innovator Companies The stem cell therapy industry is highly fragmented, and there are many companies in the world who are targeting stem cell therapeutic products. In Europe, itself there are more than 100 companies developing stem cell therapies and there are more than 400 clinics for stem cell therapy in U.S. alone. The following table gives the list of key innovators in stem cell therapeutics products across the geography. Table 58.

Key Innovator Companies Company

M

SA

United States

PL

E

Geography/Country

Asia-Pacific

Europe

90


Israel

SA

M

PL

E

Source: Scalar Market Research Analysis

91


13 Appendix Table 59.

Acronyms

Compounded Annual Growth Rate

NA

North America

EU

Europe

APAC

Asia-Pacific

ROW

Rest of the World

LA

Latin America

NR

Not Reported

R&D

Research & Development

PL

M

SA

EMA

E

CAGR

European Medicines Agency

CNS

Central Nervous System

SC

Stem Cell

100


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.